Clinical Trial Detail

NCT ID NCT03099564
Title Pembrolizumab Plus Y90 Radioembolization in HCC Subjects
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoosier Cancer Research Network
Indications

hepatocellular carcinoma

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.